Displaying One Session

Channel 2 Mon, 01.03.2021 16:00 - 17:15
Date
Mon, 01.03.2021
Room
Channel 2
Chairs
  • Alex A. Adjei (Rochester, NY, United States of America)
  • Lesley K. Seymour (Kingston, Ontario, Canada)
Where next with oncolytics? Educational session

Viro-immunotherapy and RNA-based oncolytic virotherapy (ID 40)

Lecture Time
16:00 - 16:15
Speakers
  • Alex A. Adjei (Rochester, NY, United States of America)
Room
Channel 2
Date
Mon, 01.03.2021
Time
16:00 - 17:15
Authors
  • Alex A. Adjei (Rochester, NY, United States of America)
Where next with oncolytics? Educational session

Antibody armed oncolytic viruses (ID 41)

Lecture Time
16:15 - 16:30
Speakers
  • Eric Quemeneur (Illkirch-Graffenstaden, France)
Room
Channel 2
Date
Mon, 01.03.2021
Time
16:00 - 17:15
Authors
  • Eric Quemeneur (Illkirch-Graffenstaden, France)
Where next with oncolytics? Educational session

Use of oncolytic peptides to overcome tumour heterogeneity (ID 42)

Lecture Time
16:30 - 16:45
Speakers
  • Øystein Rekdal (Oslo, Norway)
Room
Channel 2
Date
Mon, 01.03.2021
Time
16:00 - 17:15
Authors
  • Øystein Rekdal (Oslo, Norway)
Where next with oncolytics? Educational session

Oncolytics, radiation and other combinations (ID 43)

Lecture Time
16:45 - 17:00
Speakers
  • Kevin J. Harrington (London, United Kingdom)
Room
Channel 2
Date
Mon, 01.03.2021
Time
16:00 - 17:15
Authors
  • Kevin J. Harrington (London, United Kingdom)
Where next with oncolytics? Educational session

Live Q&A and discussion (ID 44)

Lecture Time
17:00 - 17:15
Speakers
  • Alex A. Adjei (Rochester, NY, United States of America)
Room
Channel 2
Date
Mon, 01.03.2021
Time
16:00 - 17:15
Authors
  • Alex A. Adjei (Rochester, NY, United States of America)
  • Lesley K. Seymour (Kingston, Ontario, Canada)
  • Eric Quemeneur (Illkirch-Graffenstaden, France)
  • Øystein Rekdal (Oslo, Norway)
  • Kevin J. Harrington (London, United Kingdom)